Understanding the Patient Selection In the Investigation of How Aspirin Impacts Treatment of Chronic Kidney Disease
Jun Ling Lu, MD, assistant professor, University of Tennessee Health Science Center, addresses what patient populations were included in the study assessing the long-term use of aspirin in patients with chronic kidney disease.
Pharmacy Times interviewed Jun Ling Lu, MD, assistant professor, Department of Medicine, University of Tennessee Health Science Center, on her presentation at the American Society of Nephrology’s Kidney Week 2021 on the association between long-term aspirin use and the progression of kidney disease.
During the discussion, Lu addressed what patient populations were included in the study assessing the long-term use of aspirin in patients with chronic kidney disease, and how patients were selected by investigators for the study.
